메뉴 건너뛰기




Volumn 15, Issue 1, 2012, Pages

A review of reported recalls involving microbiological control 2004-2011 with emphasis on FDA considerations of "objectionable organisms"

Author keywords

[No Author keywords available]

Indexed keywords

NON PRESCRIPTION DRUG;

EID: 84858436201     PISSN: 10998012     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review
Times cited : (69)

References (13)
  • 1
    • 84858436543 scopus 로고    scopus 로고
    • Accessed December, 2011
    • FDA. 2011. Enforcement Report Home Page. http://www.fda.gov/Safety/ Recalls/EnforcementReports/default.htm Accessed December, 2011.
    • (2011) Enforcement Report Home Page
  • 2
    • 37349108158 scopus 로고    scopus 로고
    • Microbial diversity in pharmaceutical product recalls and environments
    • Jimenez, L. 2007. Microbial diversity in pharmaceutical product recalls and environments. PDA Journal of Pharmaceutical Science and Technology 61(5):383-399. (Pubitemid 350305109)
    • (2007) PDA Journal of Pharmaceutical Science and Technology , vol.61 , Issue.5 , pp. 383-399
    • Jimenez, L.1
  • 4
    • 34748867409 scopus 로고    scopus 로고
    • The Harmonization of the Microbial Limits Tests
    • Sutton, S. 2006. The Harmonization of the Microbial Limits Tests Pharm Technol. 30(12):66-73
    • (2006) Pharm Technol , vol.30 , Issue.12 , pp. 66-73
    • Sutton, S.1
  • 6
    • 3543028306 scopus 로고
    • Microbial Contamination of Sterile and Non-Sterile Articles, with Special Reference to Pseudomonas cepacia
    • USP.
    • USP. 1982. Microbial Contamination of Sterile and Non-Sterile Articles, with Special Reference to Pseudomonas cepacia. Pharm Forum 8(4):2239.
    • (1982) Pharm Forum , vol.8 , Issue.4 , pp. 2239
  • 7
    • 0034982979 scopus 로고    scopus 로고
    • Setting Threshold Limits for the Significance of Objectionable Microorganisms in Oral Pharmaceutical Products
    • Manu-Tawiah, W et al. 2001. Setting Threshold Limits for the Significance of Objectionable Microorganisms In Oral Pharmaceutical Products. PDA J Pharm Sci Tech. 55(3):171-175
    • (2001) PDA J Pharm Sci Tech , vol.55 , Issue.3 , pp. 171-175
    • Manu-Tawiah, W.1
  • 8
    • 0020075662 scopus 로고
    • Bacterial Contamination of Aerosol Solutions Used to Treat Cystic Fibrosis
    • Kuhn, RJ et al. 1982. Bacterial Contamination of Aerosol Solutions Used To Treat Cystic Fibrosis. Amer J Hosp Pharm 39:308-309.
    • (1982) Amer J Hosp Pharm , vol.39 , pp. 308-309
    • Kuhn, R.J.1
  • 9
    • 0020360655 scopus 로고
    • Factors Affecting Survival of Pseudomonas cepacia in Decongestant Nasal Sprays Containing Thimerosal as Preservative
    • Decicco, B., Lee, E., et al. 1982. Factors Affecting Survival of Pseudomonas cepacia in Decongestant Nasal Sprays Containing Thimerosal as Preservative. J Pharm Sci. 71(11):1231-1234
    • (1982) J Pharm Sci , vol.71 , Issue.11 , pp. 1231-1234
    • Decicco, B.1    Lee, E.2
  • 11
    • 83755173183 scopus 로고    scopus 로고
    • Burkholderia cepacia: This Decision Is Overdue
    • Torbeck, L., et al. 2011. Burkholderia cepacia: This Decision Is Overdue. PDA J Pharm Sci Tech 65(5):535-543
    • (2011) PDA J Pharm Sci Tech , vol.65 , Issue.5 , pp. 535-543
    • Torbeck, L.1
  • 12
    • 84858404458 scopus 로고    scopus 로고
    • Commentary on "Burkholderia cepacia: This Decision Is Overdue"
    • In Press
    • Sutton, S. 2012 Commentary on "Burkholderia cepacia: This Decision Is Overdue". PDA J Pharm Sci Tech In Press.
    • (2012) PDA J Pharm Sci Tech
    • Sutton, S.1
  • 13
    • 33646241285 scopus 로고    scopus 로고
    • Microbial Identification Strategies in the Pharmaceutical Industry PDA J Pharm
    • Cundell, AM. 2006. Microbial Identification Strategies in the Pharmaceutical Industry PDA J Pharm Sci Tech 60(2):111-123.
    • (2006) Sci Tech , vol.60 , Issue.2 , pp. 111-123
    • Cundell, A.M.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.